Startups
The Sage Group is a leader in providing strategic transactional advice to health care companies in the pharmaceutical, drug delivery, diagnostics, medical device, life science, regenerative medicine and nutraceutical fields. We have an incisive understanding of defining and implementing strategy for optimal asset monetization in a highly competitive marketplace. We have executed numerous M&A and licensing deals on both buy and sell side over more than 28years. We have global operations in USA, Europe, Israel, China and Japan. The Sage Group has operated globally for over 28 years. We have served clients in Pharmaceuticals, Diagnostics, Medical Technology, Nutraceuticals and Regenerative Medicine. Sage offers its clients strategic advisory services in respect of licensing, partnering and M&A – both sellside and buyside.. We can provide a full range of services for our clients to grow their businesses through strategic partnering with large, medium and small businesses in the healthcare sector. This can include financial institutions with strategic investment objectives who seek to buy and build new bioscience entities. .
Overview
Location
United States, New Jersey, Clinton
Employees
11-50
Founded date
1994
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 8, 2026 | Sage Healthcare and Roth Capital Partners Announce European Healthcare Collaboration | Sage Healthcare logo Roth Capital Partners Logo Connecting European healthcare innovators with Sage’s transaction expertise and Roth’s U.S. capital markets platform to support financing and strategic growth This powerful collaboration allow... |
| Apr 7, 2025 | StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval | StarMab announces that US FDA has approved its Investigational New Drug (IND) application for SM2275, a novel dual-target nanobody-based anti-tumor therapy. The IND approval of SM2275 is a pivotal milestone in our mission to bring next-gene... |
| Apr 27, 2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 27th April 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| Apr 26, 2023 | BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets | BullFrog AI Holdings, Inc., a digital technology company using machine learning to usher in a new era of precision medicine, announced a strategic partnership with the Sage Group, a leader in the provision of strategic and transactional adv... |
| Jun 9, 2022 | Kinnov Therapeutics Announces Positive Phase 2 Outcome: Key Milestone with Lead Drug KT-110 for Alcohol Use Disorder | Kinnov is based in Paris, France. KINNOV Therapeutics has reached a key clinical milestone for treatment of Alcohol Use Disorder with a Phase 2 clinical study for its game changing drug KT-110. Completion of the Phase II study with KT-110, ... |
Reviews 0
FAQ about The Sage Group.
When was The Sage Group. founded?
The Sage Group. was founded in 1994.
What has the press written about The Sage Group.?
Parsers VC has collected 6 articles mentioning The Sage Group., among them “Sage Healthcare and Roth Capital Partners Announce European Healthcare Collaboration” (Oct 8, 2026) and “StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval” (Apr 7, 2025).
Is The Sage Group. still active?
The Sage Group. is probably closed: its latest activity on Parsers VC dates from Nov 4, 2026.